Evidence map›Paper›PMID 32971758›Full record

ArticlePathogens (Basel, Switzerland)2020

Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model.

William S Lawrence, Jennifer E Peel, Satheesh K Sivasubramani, Wallace B Baze, Elbert B Whorton, David W C Beasley, Jason E Comer, Dallas E Hughes, Losee L Ling, Johnny W Peterson

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Physiological Responses to Multiple Low-Doses ofPathogens (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

William S LawrenceDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Jennifer E PeelDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0003-1955-9376
Satheesh K SivasubramaniDirectorate of Environmental Health Effects Laboratory, Naval Medical Research Unit, Dayton, OH 45433, USA.
Wallace B BazeDepartment of Comparative Medicine, University of Texas MD Anderson Cancer Center, Bastrop, TX 78602, USA.
Elbert B WhortonInstitute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.
David W C BeasleyDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Jason E ComerDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Dallas E HughesNovoBiotic Pharmaceuticals, LLC, Cambridge, MA 02138, USA.
Losee L LingNovoBiotic Pharmaceuticals, LLC, Cambridge, MA 02138, USA.
Johnny W PetersonDepartment of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
The University of Texas Medical Branch at Galveston · USNovoBiotic Pharmaceuticals · USNaval Health Research Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

NIH HHS HHSN272201700040I/HHSN2720008
6 · The paper itself

Abstract

The use of antibiotics is a vital means of treating infections caused by the bacteria

Indexed as

anthraxantibioticBacillus anthracisinfectioninhalationprotective antigenrabbit model

Identifiers

PMID32971758
PMCPMC7558628
OpenAlexW3087138963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.